Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
AIM ImmunoTech Inc. (AIM)
Biological Products, (no Disgnostic Substances)
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.
2117 SW HIGHWAY 484
OCALA, FL
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/02/1995
Market Cap
16,849,613
Shares Outstanding
48,840,000
Weighted SO
48,841,656
Total Employees
N/A
Upcoming Earnings
08/13/2024
Beta
-0.3470
Last Div
0.0000
Range
0.25-0.7
Chg
0.0050
Avg Vol
281419
Mkt Cap
16849613
Exch
AMEX
Country
US
Phone
352 448 7797
DCF Diff
0.7177
DCF
-0.3581
Div Yield
0.0000
P/S
83.8289
EV Multiple
-0.5363
P/FV
2.5536
Div Yield %
0.0000
P/E
-0.5556
PEG
-0.0473
Payout
0.0000
Current Ratio
1.1718
Quick Ratio
1.1718
Cash Ratio
0.4019
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
8472.6596
CCC
-8472.6596
Gross Margin
-0.1692
Op Margin
-155.3930
Pretax Margin
-139.5274
Net Margin
-139.5274
Eff Tax Rate
-0.0179
ROA
-1.7846
ROE
-2.5633
ROCE
-4.5444
NI/EBT
1.0000
EBT/EBIT
0.8979
EBIT/Rev
-155.3930
Debt Ratio
0.1827
D/E
0.4705
LT Debt/Cap
0.0443
Total Debt/Cap
0.3200
Int Coverage
-59.2676
CF/Debt
-8.0989
Equity Multi
2.5754
Rec Turnover
0.0000
Pay Turnover
0.0431
Inv Turnover
0.0000
FA Turnover
0.2485
Asset Turnover
0.0128
OCF/Share
-0.4401
FCF/Share
-0.4526
Cash/Share
0.1904
OCF/Sales
-115.6816
FCF/OCF
1.0284
CF Coverage
-8.0989
ST Coverage
-8.9845
CapEx Coverage
-35.1770
Div&CapEx Cov
-35.1770
P/BV
2.5536
P/B
2.5536
P/S
83.8289
P/E
-0.5556
P/FCF
-0.7046
P/OCF
-0.6701
P/CF
-0.6701
PEG
-0.0473
P/S
83.8289
EV Multiple
-0.5363
P/FV
2.5536
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
4.49M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
526.04K Shares Bought (83.88 %)
101.12K Shares Sold (16.12%)
6 - 9 Months
584.56K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
566.04K Shares Bought (100.00 %)
0.00 Shares Sold (0.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 240.00K | ▼ 50.00K | ▼ 42.00K | ▲ 50.00K | ▲ 56.00K | ▲ 65.00K | ▼ 40.00K |
Cost Of Revenue | 282.00K | ▼ 217.00K | ▼ 198.00K | ▼ 176.00K | ▲ 19.78M | ▼ 70.00K | ▼ 66.00K |
Gross Profit | -42.00K | ▼ -167.00K | ▲ -156.00K | ▲ -126.00K | ▼ -19.72M | ▲ -5.00K | ▼ -26.00K |
Gross Profit Ratio | -0.18 | ▼ -3.34 | ▼ -3.71 | ▲ -2.52 | ▼ -100.00 | ▲ -0.08 | ▼ -0.65 |
Research And Development Expenses | 987.00K | ▲ 1.44M | ▲ 2.28M | ▲ 2.92M | ▼ 2.11M | ▲ 3.19M | ▼ 1.95M |
General And Administrative Expenses | 1.63M | ▼ 1.48M | ▲ 2.58M | ▲ 2.62M | ▲ 3.51M | ▲ 10.73M | ▼ 3.82M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 67.00K | ▼ -58.00K |
Selling General And Administrative Expenses | 1.63M | ▼ 1.48M | ▲ 2.58M | ▲ 2.62M | ▲ 3.51M | ▲ 10.80M | ▼ 3.76M |
Other Expenses | 955.00K | ▼ 854.00K | ▼ 135.00K | ▲ 1.78M | ▼ 741.00K | ▼ 15.00K | ▼ -3.76M |
Operating Expenses | 2.62M | ▲ 2.92M | ▲ 4.86M | ▲ 5.54M | ▲ 5.61M | ▲ 13.99M | ▼ 5.71M |
Cost And Expenses | 2.90M | ▲ 3.14M | ▲ 5.06M | ▲ 5.72M | ▼ 5.61M | ▲ 14.06M | ▼ 5.77M |
Interest Income | 1.00K | ▲ 53.00K | ▲ 88.00K | ▼ -123.00K | ▲ 333.00K | ▼ 258.00K | ▼ 81.00K |
Interest Expense | 250.00K | ▼ -110.00K | ▲ 55.00K | ▼ -100.00K | ▼ -296.00K | ▲ 634.00K | ▼ 72.00K |
Depreciation And Amortization | 174.00K | ▲ 182.00K | ▲ 192.00K | ▲ 194.00K | ▲ 1.24M | ▼ 58.00K | 58.00K |
Ebitda | -1.53M | ▼ -2.00M | ▼ -3.55M | ▼ -3.80M | ▼ -4.31M | ▼ -13.93M | ▲ -5.68M |
Ebitda Ratio | -6.38 | ▼ -39.98 | ▼ -84.50 | ▲ -75.90 | ▼ -77.00 | ▼ -100.00 | -100.00 |
Operating Income | -2.66M | ▼ -3.09M | ▼ -5.15M | ▼ -7.45M | ▲ -5.56M | ▼ -13.99M | ▲ -5.73M |
Operating Income Ratio | -11.09 | ▼ -61.76 | ▼ -122.62 | ▼ -148.90 | ▲ -99.21 | ▼ -215.23 | ▲ -143.35 |
Total Other Income Expenses Net | 1.30M | ▲ 1.74M | ▼ 1.05M | ▼ -80.00K | ▲ 1.17M | ▲ 1.41M | ▼ -83.00K |
Income Before Tax | -1.61M | ▲ -1.19M | ▼ -3.93M | ▼ -5.85M | ▲ -4.39M | ▼ -12.58M | ▲ -5.82M |
Income Before Tax Ratio | -6.70 | ▼ -23.76 | ▼ -93.67 | ▼ -100.00 | ▲ -78.38 | ▼ -100.00 | -100.00 |
Income Tax Expense | 1.21M | ▼ 744.00K | ▲ 1.24M | ▼ -100.00K | ▲ -93.00K | ▲ 492.00K | ▼ 0.00 |
Net Income | -1.61M | ▲ -1.19M | ▼ -3.93M | ▼ -5.85M | ▲ -4.30M | ▼ -12.58M | ▲ -5.82M |
Net Income Ratio | -6.70 | ▼ -23.76 | ▼ -93.67 | ▼ -100.00 | ▲ -76.71 | ▼ -100.00 | -100.00 |
Eps | -1.39 | ▲ -0.07 | ▼ -0.09 | ▼ -0.12 | ▲ -0.09 | ▼ -0.26 | ▲ -0.12 |
Eps Diluted | -1.39 | ▲ -0.07 | ▼ -0.09 | ▼ -0.12 | ▲ -0.09 | ▼ -0.26 | ▲ -0.12 |
Weighted Average Shs Out | 1.10M | ▲ 17.49M | ▲ 45.73M | ▲ 47.85M | ▲ 48.08M | ▲ 49.10M | ▲ 49.46M |
Weighted Average Shs Out Dil | 1.16M | ▲ 17.49M | ▲ 45.73M | ▲ 47.85M | ▲ 48.08M | ▲ 49.10M | ▲ 49.46M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 299.00K | ▲ 1.47M | ▲ 38.50M | ▼ 32.09M | ▼ 27.05M | ▼ 5.44M | ▼ 3.30M |
Short Term Investments | 1.53M | ▲ 7.31M | ▼ 501.00K | ▲ 16.18M | ▼ 7.14M | ▲ 7.63M | ▲ 7.65M |
Cash And Short Term Investments | 1.83M | ▲ 8.78M | ▲ 39.00M | ▲ 48.27M | ▼ 34.19M | ▼ 13.07M | ▼ 10.94M |
Net Receivables | 1.09M | ▼ 820.00K | ▲ 1.12M | ▲ 1.64M | ▲ 1.68M | ▼ 1.18M | ▼ 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 880.00K | ▼ 848.00K | ▼ 184.00K | ▲ 304.00K | ▲ 455.00K | ▼ 302.00K | ▲ 364.00K |
Total Current Assets | 3.80M | ▲ 10.45M | ▲ 40.31M | ▲ 50.21M | ▼ 36.32M | ▼ 14.56M | ▼ 11.31M |
Property Plant Equipment Net | 7.78M | ▼ 7.27M | ▼ 6.65M | ▼ 4.20M | ▼ 1.02M | ▼ 824.00K | ▲ 881.00K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 912.00K | ▲ 1.15M | ▲ 1.50M | ▲ 1.97M | ▼ 1.94M | ▲ 2.31M | ▲ 2.31M |
Goodwill And Intangible Assets | 912.00K | ▲ 1.15M | ▲ 1.50M | ▲ 1.97M | ▼ 1.94M | ▲ 2.31M | ▲ 2.31M |
Long Term Investments | 0.00 | 0.00 | ▲ 15.38M | ▼ 0.00 | ▼ -30.55M | ▲ -1.00 | ▲ 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 30.55M | ▼ 38.42K | ▼ 0.00 |
Other Non Current Assets | 1.35M | ▲ 1.35M | ▼ 748.00K | ▲ 1.32M | ▼ 1.20M | ▲ 1.69M | ▲ 1.69M |
Total Non Current Assets | 10.05M | ▼ 9.77M | ▲ 24.27M | ▼ 7.49M | ▼ 4.17M | ▲ 4.86M | ▲ 4.88M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 13.85M | ▲ 20.22M | ▲ 64.58M | ▼ 57.70M | ▼ 40.49M | ▼ 19.42M | ▼ 16.19M |
Account Payables | 680.00K | ▼ 472.00K | ▼ 383.00K | ▼ 198.00K | ▲ 377.00K | ▲ 6.44M | ▲ 6.57M |
Short Term Debt | 3.61M | ▼ 252.00K | ▲ 277.00K | ▼ 37.00K | ▲ 178.00K | ▲ 223.00K | ▲ 1.86M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 806.00K | ▼ 189.00K | ▲ 212.00K | ▼ 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Other Current Liabilities | 199.00K | ▲ 214.00K | ▲ 230.00K | ▲ 438.00K | ▲ 806.00K | ▲ 1.99M | ▼ 1.45M |
Total Current Liabilities | 5.29M | ▼ 1.13M | ▼ 1.10M | ▼ 673.00K | ▲ 1.36M | ▲ 8.65M | ▲ 9.88M |
Long Term Debt | 2.32M | ▲ 6.13M | ▼ 2.01M | ▼ 112.00K | ▲ 659.00K | ▼ 495.00K | ▲ 950.00K |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -495.00K | ▲ 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 29.43M | ▼ 36.82K | ▼ 0.00 |
Other Non Current Liabilities | 1.06M | ▼ 57.00K | ▲ 180.00K | ▼ 35.00K | ▼ -29.43M | ▲ 495.00K | ▲ 537.00K |
Total Non Current Liabilities | 3.38M | ▲ 6.19M | ▼ 2.19M | ▼ 147.00K | ▲ 659.00K | ▼ 531.82K | ▲ 1.49M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 2.32M | ▼ 2.26M | ▼ 2.06M | ▼ 149.00K | ▲ 837.00K | ▼ 495.00K | ▲ 537.00K |
Total Liabilities | 8.67M | ▼ 7.31M | ▼ 3.29M | ▼ 820.00K | ▲ 2.02M | ▲ 9.18M | ▲ 11.36M |
Preferred Stock | 0.00 | ▲ 778.00K | ▼ 732.00K | ▼ 715.00K | ▼ 696.00K | ▼ 689.00K | 689.00K |
Common Stock | 49.00K | ▼ 10.00K | ▲ 42.00K | ▲ 48.00K | 48.00K | ▲ 49.00K | ▲ 50.00K |
Retained Earnings | -318.57M | ▼ -328.11M | ▼ -341.97M | ▼ -361.10M | ▼ -380.55M | ▼ -409.51M | ▼ -415.33M |
Accumulated Other Comprehensive Income Loss | -3.00K | ▼ -8.55M | ▲ -47.00K | ▲ 0.00 | 0.00 | 0.00 | ▼ -689.00K |
Other Total Stockholders Equity | 323.70M | ▲ 348.77M | ▲ 402.54M | ▲ 417.22M | ▲ 418.27M | ▲ 419.00M | ▲ 420.10M |
Total Stockholders Equity | 5.17M | ▲ 12.91M | ▲ 61.29M | ▼ 56.88M | ▼ 38.47M | ▼ 10.23M | ▼ 4.83M |
Total Equity | 5.17M | ▲ 12.91M | ▲ 61.29M | ▼ 56.88M | ▼ 38.47M | ▼ 10.23M | ▼ 4.83M |
Total Liabilities And Stockholders Equity | 13.85M | ▲ 20.22M | ▲ 64.58M | ▼ 57.70M | ▼ 40.49M | ▼ 19.42M | ▼ 16.19M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 13.85M | ▲ 20.22M | ▲ 64.58M | ▼ 57.70M | ▼ 40.49M | ▼ 19.42M | ▼ 16.19M |
Total Investments | 1.53M | ▲ 7.31M | ▲ 15.88M | ▲ 16.18M | ▼ 7.14M | ▲ 7.63M | ▲ 7.65M |
Total Debt | 5.93M | ▲ 6.38M | ▼ 2.29M | ▼ 149.00K | ▲ 837.00K | ▼ 718.00K | ▲ 3.35M |
Net Debt | 5.63M | ▼ 4.91M | ▼ -36.22M | ▲ -31.94M | ▲ -26.22M | ▲ -4.72M | ▲ 55.00K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -1.61M | ▲ -1.19M | ▼ -3.93M | ▼ -5.85M | ▲ -4.39M | ▼ -12.58M | ▲ -5.82M |
Depreciation And Amortization | 174.00K | ▲ 182.00K | ▲ 192.00K | ▲ 194.00K | ▼ 170.00K | ▼ 58.00K | 58.00K |
Deferred Income Tax | -342.00K | ▲ 245.00K | ▲ 1.28M | ▼ -1.78M | ▲ 946.00K | ▲ 2.30M | ▼ 0.00 |
Stock Based Compensation | 178.00K | ▲ 204.00K | ▲ 440.00K | ▼ 248.00K | ▼ 162.00K | ▼ 61.00K | ▲ 80.00K |
Change In Working Capital | -781.00K | ▼ -1.65M | ▲ -873.00K | ▲ -136.00K | ▼ -2.91M | ▲ 2.08M | ▼ 766.00K |
Accounts Receivables | -1.07M | ▲ -758.00K | ▲ -754.00K | ▲ 28.00K | ▼ -1.68M | ▲ -1.18M | ▲ 0.00 |
Inventory | 0.00 | ▼ -672.00K | ▲ 0.00 | 0.00 | ▲ 1.68M | ▼ -1.00 | ▲ 0.00 |
Accounts Payables | -111.00K | ▼ -231.00K | ▲ 176.00K | ▼ -171.00K | ▼ -579.00K | ▲ 3.66M | ▼ 124.00K |
Other Working Capital | 396.00K | ▼ 11.00K | ▼ -295.00K | ▲ 7.00K | ▼ -2.33M | ▲ -398.00K | ▲ 642.00K |
Other Non Cash Items | -41.00K | ▼ -82.00K | ▲ 44.00K | ▲ 1.57M | ▼ -52.00K | ▼ -1.69M | ▲ 170.00K |
Net Cash Provided By Operating Activities | -2.42M | ▲ -2.29M | ▼ -2.85M | ▼ -5.75M | ▼ -6.07M | ▼ -9.76M | ▲ -4.82M |
Investments In Property Plant And Equipment | -12.00K | ▼ -95.00K | ▼ -285.00K | ▲ -155.00K | ▼ -175.00K | ▼ -198.00K | ▲ -50.00K |
Acquisitions Net | 0.00 | 0.00 | ▲ 276.00K | ▼ 47.00K | ▲ 3.60M | ▼ 47.00K | ▼ 0.00 |
Purchases Of Investments | 0.00 | ▼ -5.19M | ▲ -1.44M | ▼ -20.92M | ▲ -1.06M | ▲ -438.00K | ▲ -158.00K |
Sales Maturities Of Investments | -1.51M | ▲ 0.00 | ▲ 1.55M | ▲ 21.44M | ▼ 1.00M | ▼ 375.00K | ▼ 50.00K |
Other Investing Activities | 0.00 | 0.00 | ▼ -276.00K | ▲ -47.00K | ▲ 3.75M | ▼ -224.00K | ▲ -158.00K |
Net Cash Used For Investing Activities | -1.52M | ▼ -5.29M | ▲ -182.00K | ▲ 364.00K | ▲ 3.36M | ▼ -214.00K | ▲ -158.00K |
Debt Repayment | -83.00K | ▼ -2.30M | ▲ -141.00K | ▼ -4.73M | ▲ 0.00 | 0.00 | ▼ -2.50M |
Common Stock Issued | 166.00K | ▼ -4.00K | ▲ 3.18M | ▼ 125.00K | ▼ 0.00 | ▲ 147.00K | ▲ 329.00K |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 98.00K | ▲ 1.73M | ▼ 0.00 | ▲ 4.73M | ▼ 0.00 | ▲ 147.00K | ▲ 329.00K |
Net Cash Used Provided By Financing Activities | 181.00K | ▼ -568.00K | ▲ 3.04M | ▼ 125.00K | ▼ 0.00 | ▲ 147.00K | ▲ 2.83M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | -3.76M | ▼ -8.15M | ▲ 5.00K | ▼ -5.26M | ▲ -2.71M | ▼ -9.83M | ▲ -2.14M |
Cash At End Of Period | 299.00K | ▲ 1.47M | ▲ 38.50M | ▼ 32.09M | ▼ 27.05M | ▼ 5.44M | ▼ 3.30M |
Cash At Beginning Of Period | 4.06M | ▲ 9.62M | ▲ 38.50M | ▼ 37.35M | ▼ 29.76M | ▼ 15.26M | ▼ 5.44M |
Operating Cash Flow | -2.42M | ▲ -2.29M | ▼ -2.85M | ▼ -5.75M | ▼ -6.07M | ▼ -9.76M | ▲ -4.82M |
Capital Expenditure | -12.00K | ▼ -95.00K | ▼ -285.00K | ▲ -155.00K | ▼ -175.00K | ▼ -198.00K | ▲ -50.00K |
Free Cash Flow | -2.43M | ▲ -2.38M | ▼ -3.14M | ▼ -5.90M | ▼ -6.24M | ▼ -9.96M | ▲ -4.87M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)